Lazard’s addition of Dr. Geoffrey Porges as Managing Director in the Healthcare Advisory Group underscores the firm’s commitment to enhancing its expertise in the biopharmaceutical sector.
NEW YORK–(BUSINESS WIRE)–Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. “We are thrilled to welcome Geoffrey to Lazard,” said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. “His deep understanding of the biopharmaceutical industry’s strategic and financial landscape, coupled with his ability to help companies translate
Source: Original Press Release
